by David Cassak
Traditionally, US and European hospital supply distributors have taken very different paths toward the same goal: arguing for the value...
Krauth Medical: Redefining European Hospital Supply
Unlike their logistics-driven counterparts in the US, European hospital supply distributors have stressed their role as exclusive sales agents for selected manufacturers. But in Germany, cost pressures are forcing hospitals to look at process as much as product, leading suppliers like Krauth into an array of service-oriented, asset management-based businesses.
More from Global Vision
• By
Leading industry experts have spoken to In Vivo about how investment, a change in mindset and a fresh approach to policy may allow Italy to kick-start its biotech ecosystem.
• By
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
• By
Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.
• By
The UK government has prioritized synthetic biology and created a "concierge service" for biotechs just as the US cuts science funding.
More from In Vivo
• By
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
• By
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.